-+ 0.00%
-+ 0.00%
-+ 0.00%

INCYTE ANNOUNCES FUNDING OF MINJUVI® (TAFASITAMAB) FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA THROUGH ONTARIO'S FAST PROGRAM

Reuters·09/10/2026 13:00:12

Please log in to view news